Eagle Bay Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-182
Closed -$67.2K 374
2024
Q4
$67.2K Sell
182
-7
-4% -$2.93K 0.04% 292
2024
Q3
$98.4K Sell
189
-2
-1% -$1.07K 0.04% 301
2024
Q2
$104K Sell
191
-3
-2% -$1.59K 0.06% 205
2024
Q1
$101K Buy
194
+17
+10% +$8.46K 0.06% 210
2023
Q4
$83.5K Sell
177
-4
-2% -$1.85K 0.05% 233
2023
Q3
$78.9K Buy
181
+9
+5% +$4.08K 0.04% 300
2023
Q2
$76.5K Sell
172
-3
-2% -$1.38K 0.04% 280
2023
Q1
$80.5K Sell
175
-22
-11% -$10.5K 0.04% 294
2022
Q4
$101K Sell
197
-619
-76% -$314K 0.06% 230
2022
Q3
$371K Sell
816
-2
-0.2% -$957 0.23% 72
2022
Q2
$395K Buy
818
+206
+34% +$102K 0.24% 67
2022
Q1
$301K Sell
612
-226
-27% -$103K 0.25% 78
2021
Q4
$389K Buy
838
+159
+23% +$66.9K 0.25% 65
2021
Q3
$252K Buy
679
+198
+41% +$75.2K 0.14% 107
2021
Q2
$186K Buy
+481
New +$184K 0.15% 92

Other funds holding ELV

Eagle Bay Advisors's ELV Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 182 shares — an estimated $67.2K sold.

Eagle Bay Advisors first reported a position in ELV in Q2 2021 and held it in 15 quarters. The position peaked at $395K in Q2 2022. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 182 Elevance Health shares in Q1 2025, an estimated $67.2K.
  • Eagle Bay Advisors first reported a position in Elevance Health in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Elevance Health position peaked at $395K in Q2 2022.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.